Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype

Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). The LRRK2 physiological and pathological function is still debated. However, different experimental evidence based on LRRK2 cellular localization and LRRK2 protein interactors sugges...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cell Mol Med
Hauptverfasser: Rassu, Mauro, Biosa, Alice, Galioto, Manuela, Fais, Milena, Sini, Paola, Greggio, Elisa, Piccoli, Giovanni, Crosio, Claudia, Iaccarino, Ciro
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Short Communications
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850958/
https://ncbi.nlm.nih.gov/pubmed/31560168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14674
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge